109 related articles for article (PubMed ID: 7299675)
1. Pharmacokinetics of isosorbide dinitrate in rhesus monkey, cynomolgus monkey, and baboon.
Doyle E; Chasseaud LF
J Pharm Sci; 1981 Nov; 70(11):1270-2. PubMed ID: 7299675
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetics of antipyrine (phenazone) in the baboon, cynomolgus monkey and rhesus monkey.
Doyle E; Chasseaud LF
Toxicology; 1981; 19(2):159-68. PubMed ID: 7268788
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of frusemide in female rhesus monkeys, cynomolgus monkeys and baboons.
Doyle E; Chasseaud LF; Miller JN
Comp Biochem Physiol C Comp Pharmacol; 1982; 71C(1):89-93. PubMed ID: 6121675
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion.
Santoni Y; Iliadis A; Cano JP; Luccioni R; Frances Y
J Pharmacokinet Biopharm; 1986 Feb; 14(1):1-17. PubMed ID: 3746630
[TBL] [Abstract][Full Text] [Related]
5. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects.
Taylor T; Chasseaud LF; Doyle E; Darragh A; O'Kelly DA; Fitzgerald D
Biopharm Drug Dispos; 1980; 1(3):149-56. PubMed ID: 7448342
[TBL] [Abstract][Full Text] [Related]
7. Plasma isosorbide dinitrate concentrations in human subjects after administration of standard and sustained-release formulations.
Assinder DF; Chasseaud LF; Taylor T
J Pharm Sci; 1977 Jun; 66(6):775-8. PubMed ID: 577507
[TBL] [Abstract][Full Text] [Related]
8. Isosorbide 5-mononitrate pharmacokinetics in humans.
Taylor T; Chasseaud LF; Major R; Doyle E; Darragh A
Biopharm Drug Dispos; 1981; 2(3):255-63. PubMed ID: 7295882
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefovecin in cynomolgus macaques (Macaca fascicularis), olive baboons (Papio anubis), and rhesus macaques (Macaca mulatta).
Raabe BM; Lovaglio J; Grover GS; Brown SA; Boucher JF; Yuan Y; Civil JR; Gillhouse KA; Stubbs MN; Hoggatt AF; Halliday LC; Fortman JD
J Am Assoc Lab Anim Sci; 2011 May; 50(3):389-95. PubMed ID: 21640036
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of isosorbide dinitrate administered by intravenous infusion to hypertensive patients (author's transl)].
Frydman A; Levenson J; Simon A; Safar M; Bieder A; Bertharion J; Gaillot J
Nouv Presse Med; 1982 Jun; 11(27):2049-56. PubMed ID: 7110964
[TBL] [Abstract][Full Text] [Related]
13. Newer aspects of the pharmacokinetics of organic nitrates.
Chasseaud LF
Z Kardiol; 1983; 72 Suppl 3():20-3. PubMed ID: 6666223
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of organic nitrates.
Bogaert MG
Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
[TBL] [Abstract][Full Text] [Related]
15. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
Geigenberger A; Degen J; Maier-Lenz H
Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of isosorbide dinitrate after oral administration of a sustained-release formulation to human subjects.
Assinder DF; Chasseaud LF; Hunter JO; Jung RJ; Taylor T
Arzneimittelforschung; 1977; 27(1):156-8. PubMed ID: 576817
[TBL] [Abstract][Full Text] [Related]
17. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
Straehl P; Galeazzi RL; Soliva M
Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
[TBL] [Abstract][Full Text] [Related]
18. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
Straehl P; Galeazzi RL
Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
[TBL] [Abstract][Full Text] [Related]
19. Isosorbide 5-mononitrate kinetics.
Major RM; Taylor T; Chasseaud LF; Darragh A; Lambe RF
Clin Pharmacol Ther; 1984 May; 35(5):653-9. PubMed ID: 6713775
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of doxylamine given as Bendectin in the pregnant monkey and baboon.
Rowland JM; Slikker W; Holder CL; Denton R; Prahalada S; Young JF; Hendrickx AG
Reprod Toxicol; 1989; 3(3):197-202. PubMed ID: 2520523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
